Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.05.12.653597

Targeting of CIP4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction

Abstract

BackgroundCalcineurin in a pleiotropic signaling enzyme that promotes pathological cardiac remodeling but also cardioprotection in ischemia-reperfusion injury. In addition, calcineurin inhibitors are immunosuppressants. This pleiotropy has precluded the use of calcineurin inhibitors as treatments for heart failure. Cdc42-interacting protein 4 (CIP4/TRIP10) is an endosomal scaffold protein that organizes a calcium and calcineurin A{beta}2 (CaNA{beta}2) signaling compartment activated by G-protein coupled receptors independently of contractile calcium. CIP4 binds CaNA{beta}2 via the CaNA{beta}-specific N-terminal polyproline (PP) domain. We previously showed that targeting of CIP4-CaNA{beta}2 signalosomes inhibited pathological cardiac hypertrophy and the development of heart failure induced by chronic pressure overload in mice. It is unknown whether CIP4-CaNA{beta}2 signalosomes contribute to cardioprotection and/or cardiac remodeling in ischemic heart disease. MethodsCIP4 conditional knock-out (CKO) mice were studied by echocardiography with strain analysis and histology following ischemia-reperfusion (I/R) injury and permanent left coronary artery (LCA) ligation to induce myocardial infarction. Wildtype C57BL/6NJ mice were transduced with adeno-associated virus (AAV) engineered for cardiomyocyte-specific expression of either a CaNA{beta}2 shRNA to inhibit CaNA{beta}2 expression, a VIVIT peptide to inhibit CaN-NFAT signaling, or a CaNA{beta}2 PP peptide to block CIP4-CaNA{beta}2 binding. AAV-transduced mice were studied by I/R injury. Additional mice were subjected to permanent LCA ligation and subsequently treated with AAV to test the effects of CaN inhibition in chronic ischemic cardiomyopathy. The effects of CaNA{beta}2 PP-GFP expression on primary T-cell activation were studied in vitro. ResultsCIP4 CKO mice and mice expressing the PP anchoring disruptor peptide exhibited preserved cardiac function after I/R injury and decreased infarct size and preserved cardiac function 8 weeks after myocardial infarction by permanent LCA ligation. In contrast, cardiomyocyte-specific depletion of CaNA{beta}2 and VIVIT peptide expression worsened outcome after I/R injury and in chronic ischemic cardiomyopathy. In addition, in contrast to cardiomyocytes, PP-mediated CaNA{beta} anchoring inhibition had no effect on T-cell activation and cytokine expression in vitro. ConclusionsCIP4-CaNA{beta}2 signalosomes promote adverse cardiac remodeling and are not cardioprotective. Proof-of-concept is provided for the treatment of ischemic cardiomyopathy by a PP anchoring disruptor gene therapy. Targeting these complexes may be beneficial in cardiovascular diseases, including ischemic cardiomyopathy and acute myocardial infarction. Clinical PerspectiveO_ST_ABSWhat is New?C_ST_ABSO_LITargeting CIP4, which is a scaffold protein for the phosphatase calcineurin, improves cardiac function in mice after acute myocardial infarction due to ischemia-reperfusion injury and in chronic ischemic cardiomyopathy. C_LIO_LIGene therapy-based expression of a calcineurin A{beta}-derived polyproline peptide, which can compete CIP4-calcineurin binding, is beneficial in acute and chronic myocardial infarction. C_LI What Are the Clinical Implications?O_LIThis study establishes CIP4 signalosomes as a new drug target for the treatment of ischemia-reperfusion injury and chronic pathological cardiac remodeling. C_LIO_LIThis study provides proof-of-concept for a new gene therapy approach to treating acute myocardial infarction and chronic ischemic cardiomyopathy. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Samuelsson, A.-M., Bayer, A. L., Li, J., Li, Y., Lewis, D., Turcotte, M., Dodge-Kafka, K., Alcaide, P., Kapiloff, M. S.. 2025-05-15. Targeting of CIP4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction. https://doi.org/10.1101/2025.05.12.653597

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The canine hair metabolome encodes age and coat exposure in over 700 dogs

Hair can be collected noninvasively and stored for years, making it a practical sample for studying physiology and environmental exposure. Yet the chemical information it carries in dogs remains largely unexplored. We profiled 782 banked hair samples from 700 Golden Retrievers by untargeted liquid chromatography-mass spectrometry, detecting 4,533 compound groups and revealing an unexpectedly rich chemical profile. Prominent signals reflected skin-surface and hair chemistry, including amino acids, peptides and urocanic acid, alongside surfactants, plasticizers and pesticides detectable despite washing. A signal annotated as imidacloprid distinguished dogs receiving topical products containing this insecticide from dogs receiving no flea or tick preventive (AUC 0.865). Hair chemistry also varied with age, most strongly between puppyhood and early adulthood. Oxidized lipids generally declined, whereas amino acids and peptides remained largely stable. A multivariate model estimated age with moderate accuracy (cross-validated r = 0.66) and assigned a higher age to the later sample in 64 of 75 repeatedly sampled dogs. Because age and collection date were strongly correlated, their effects could not be fully separated, although date-restricted analyses supported an age-related contribution. Together, these findings establish banked dog hair as a promising resource for studying chemical exposure and life-stage-associated changes in chemistry.

physiology↗

Dietary Human HSP90 Promotes Longevity and Healthspan in Caenorhabditis elegans via a Multi-Branched Stress Signaling Pathway

The loss of proteostasis is one of the primary drivers of aging. Despite the important role of the molecular chaperone HSP90 in maintaining proteostasis, its systemic role in aging appears contradictory because its inhibitors can effectively extend lifespan across diverse species. This study showed that dietary HSP90 supplementation via Escherichia coli significantly extended lifespan and healthspan of Caenorhabditis elegans without fertility trade-offs. Exogenous HSP90 likely acts as an extracellular signaling ligand that engages downstream kinase networks to drive the activation of three major longevity-associated transcription factors: DAF-16, SKN-1, and HSF-1. In addition, we demonstrated the additive effect of combining dietary HSP90 supplementation with the senolytic HSP90 inhibitor tanespimycin, indicating that extracellular proteostatic signaling and the intracellular inhibition of HSP90 can work together to enhance longevity. Finally, we engineered an antibiotic-free E. coli Nissle 1917 probiotic that constitutively expresses HSP90, which successfully extended the lifespan of C. elegans.

physiology↗

Sex differences in myocardial ketone oxidation capacity in cardiometabolic disease with coincident ischemic heart disease

Background: Myocardial infarction (MI) in patients with heart failure with preserved ejection fraction (HFpEF) is associated with worse outcomes than MI in individuals without HFpEF. However, the molecular mechanisms underlying this increased vulnerability remain poorly understood. We investigated sex differences in cardiac ketone body (KB) metabolism in patients with diabetes-associated ischemic heart disease, and in a mouse model of HFpEF complicated by MI (HFpEF-MI). Methods: Cardiac BDH1 and OXCT1 expression was assessed in male and female patients with diabetes, with or without ischemic heart disease. Male and female mice received a high-fat diet and L-NAME for 10 weeks to induce HFpEF, followed by coronary artery ligation to induce MI. Glucose tolerance, cardiac function, survival, cardiac KB oxidative capacity, and circulating KB levels were evaluated. Results: Cardiac BDH1 and OXCT1 abundance was significantly reduced in male patients with diabetes-associated ischemic heart disease but preserved in female patients. In mice, 10 weeks of high-fat diet and L-NAME administration increased fasting blood glucose and impaired glucose tolerance. MI reduced systolic function in control and HFpEF mice of both sexes. Male HFpEF-MI mice exhibited higher mortality than female HFpEF-MI mice. Consistent with our human results, male HFpEF-MI mice showed reduced cardiac ketolytic enzyme expression alongside elevated circulating KB levels, whereas female mice maintained cardiac KB oxidative capacity. Conclusion: Reduced cardiac ketolytic enzyme expression and impaired KB oxidative capacity are associated with greater mortality in male HFpEF-MI mice, whereas female mice exhibit preserved KB oxidative capacity and improved survival. Similar sex differences in ketolytic enzyme expression were observed in patients with diabetes-associated ischemic heart disease. These findings identify cardiac ketone metabolism as a potential therapeutic target warranting further investigation in HFpEF complicated by MI.

physiology↗